Celia Painous

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.

Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 04, 2026

Synucleinopathy-like clinical features and biologically defined synuclein seeding in PSP-Parkinsonism: an imperfect match.

Synucleinopathy-like clinical features and biologically defined synuclein seeding in PSP-Parkinsonism: an imperfect match.

Journal: NPJ Parkinson's disease

Published: December 29, 2025

Neurofilament light chain as a diagnostic and prognostic biomarker in atypical parkinsonisms: current evidence, new data, challenges, and future directions.

Neurofilament light chain as a diagnostic and prognostic biomarker in atypical parkinsonisms: current evidence, new data, challenges, and future directions.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: September 30, 2025

An eight-year follow-up of the CMSAR: assessing how the new MDS criteria and biomarkers impact diagnostic accuracy.

An eight-year follow-up of the CMSAR: assessing how the new MDS criteria and biomarkers impact diagnostic accuracy.

Journal: NPJ Parkinson's disease

Published: June 16, 2025

Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases.

Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 16, 2025

Biomarkers of neurodegenerative parkinsonisms: From current clinical to future biological definitions - literature review and our experience.

Biomarkers of neurodegenerative parkinsonisms: From current clinical to future biological definitions - literature review and our experience.

Journal: Neurologia i neurochirurgia polska

Published: December 15, 2024

Correction: Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective.

Correction: Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective.

Journal: Neurology and therapy

Published: November 21, 2024

A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC.

A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC.

Journal: European journal of human genetics : EJHG

Published: July 17, 2024

Revisiting sex-gender disparities in MSA: An unfinished narrative.

Revisiting sex-gender disparities in MSA: An unfinished narrative.

Journal: Parkinsonism & related disorders

Published: July 10, 2024

Long-term response to aminopyridines in a cohort of patients with ataxia associated with downbeat nystagmus due to the FGF14 GAA expansion.

Long-term response to aminopyridines in a cohort of patients with ataxia associated with downbeat nystagmus due to the FGF14 GAA expansion.

Journal: Neurologia

Published: May 20, 2024

Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective.

Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective.

Journal: Neurology and therapy

Published: April 15, 2024

Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?

Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?

Journal: Parkinsonism & related disorders

Published: February 23, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026